Senior Vice President and General Manager, Oracle Health Sciences
Steve Rosenberg, senior vice president and general manager of Oracle Health Sciences, has more than 30 years of experience leading development, services, support, and consulting, in addition to significant industry experience in life sciences and healthcare. Some of Rosenberg's key contributions to the industry include cloud-based solutions including an integrated approach to clinical trial management, new methodologies for patient-reported outcomes, and the introduction of advanced analytics for at-risk healthcare payers and providers.
As a leader and industry veteran with a range of experiences in life sciences and healthcare technology and services, Rosenberg has the knowledge and experience to address and influence the changing life sciences landscape, utilizing his deep domain understanding, customer relationships, and technology vision.
As senior vice president and manager of the Medical Management Division at HPR, Inc. (acquired by McKesson HBOC) and as senior vice president of Development and Client Services at W3Health, a healthcare analytic software and services technology startup, Rosenberg gained a unique healthcare perspective to broaden his holistic view of the life sciences industry. These experiences provide him with the payer and provider perspective needed to understand the end-to-end business process and the changing dynamics affecting life sciences R&D.
Rosenberg's experience also includes eight months as chief operating officer for PHT Corporation, a technology and service leader in the electronic patient-reported outcome (ePRO) market space. He was instrumental in developing PHT's strategy for the patient suite and the patient-centric clinical trial.
Most notably, Rosenberg was the visionary and lead evangelist for the integrated clinical technology suite introduced by Phase Forward and used by 9 of the top 10 global biopharmaceutical companies. As senior vice president of Software and Services at Phase Forward, Rosenberg was an integral member of the senior management team and championed the integrated technology approach. During his tenure, Phase Forward went public in 2005, and with his technology guidance dominated the clinical R&D solutions market. In 2009, Phase Forward achieved US$213 million in revenue with approximately 1,000 employees and was the #1 clinical R&D solution provider.